Evaluation of monophosphoryl lipid A as a vaccine adjuvant for a multivalent pneumococcal glycoconjugate vaccine in mice.

被引:0
|
作者
Dermody, KM [1 ]
Mason, KW [1 ]
La Posta, VJ [1 ]
机构
[1] Lederle Vaccines & Pediat, W Henrietta, NY 14586 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3557
引用
收藏
页码:A612 / A612
页数:1
相关论文
共 50 条
  • [31] Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants
    Rohokale, Rajendra
    Guo, Jiatong
    Guo, Zhongwu
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (09) : 7458 - 7469
  • [32] The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4 (June, pg 1628, 2007)
    Mata-Haro, V.
    SCIENCE, 2007, 317 (5841) : 1036 - 1036
  • [33] THE ADJUVANT PROPERTIES OF A NONTOXIC MONOPHOSPHORYL LIPID-A IN HYPORESPONSIVE AND AGING MICE
    TOMAI, MA
    SOLEM, LE
    JOHNSON, AG
    RIBI, E
    EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 1986, 6 (03): : 191 - 191
  • [34] Lipid tucaresol as an adjuvant for methamphetamine vaccine development
    Collins, K. C.
    Schlosburg, J. E.
    Lockner, J. W.
    Bremer, P. T.
    Ellis, B. A.
    Janda, K. D.
    CHEMICAL COMMUNICATIONS, 2014, 50 (31) : 4079 - 4081
  • [35] Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats
    Kamphuis, Tobias
    Shafique, Muhammad
    Meijerhof, Tjarko
    Stegmann, Toon
    Wilschut, Jan
    de Haan, Aalzen
    VACCINE, 2013, 31 (17) : 2169 - 2176
  • [36] USE OF ADJUVANT CONTAINING MYCOBACTERIAL CELL-WALL SKELETON, MONOPHOSPHORYL LIPID-A, AND SQUALANE IN MALARIA CIRCUMSPOROZOITE PROTEIN VACCINE
    RICKMAN, LS
    GORDON, DM
    WISTAR, R
    KRZYCH, U
    GROSS, M
    HOLLINGDALE, MR
    EGAN, JE
    CHULAY, JD
    HOFFMAN, SL
    LANCET, 1991, 337 (8748) : 998 - 1001
  • [37] EFFECT OF CELL-WALL SKELETON AND MONOPHOSPHORYL LIPID-A ADJUVANT ON THE IMMUNOGENICITY OF A MURINE B16-MELANOMA VACCINE
    JOHNSTON, D
    BYSTRYN, JC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (17) : 1240 - 1245
  • [38] SAFETY, IMMUNOGENICITY, AND EFFICACY OF A MALARIA SPOROZOITE VACCINE ADMINISTERED WITH MONOPHOSPHORYL LIPID A, CELL-WALL SKELETON OF MYCOBACTERIA, AND SQUALANE AS ADJUVANT
    HOFFMAN, SL
    EDELMAN, R
    BRYAN, JP
    SCHNEIDER, I
    DAVIS, J
    SEDEGAH, M
    GORDON, D
    CHURCH, P
    GROSS, M
    SILVERMAN, C
    HOLLINGDALE, M
    CLYDE, D
    SZTEIN, M
    LOSONSKY, G
    PAPARELLO, S
    JONES, TR
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 51 (05) : 603 - 612
  • [39] Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid a adjuvant vaccine
    Sasaki, S
    Hamajima, K
    Fukushima, J
    Ihata, A
    Ishii, N
    Gorai, I
    Hirahara, F
    Mohri, H
    Okuda, K
    INFECTION AND IMMUNITY, 1998, 66 (02) : 823 - 826
  • [40] Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers
    Pichichero, ME
    Shelly, MA
    Treanor, JJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (01) : 72 - 74